Entries by admicec

19. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients

McClelland S 3rd, Leberknight J, Guadagnolo BA, Coleman CN, Petereit DG. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients. Adv Radiat Oncol. 2017 Aug 26;3(1):3-7. doi: 10.1016/j.adro.2017.08.010. PMID: 29556572; PMCID: PMC5856975.

15. Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care

Rodin D, Longo J, Sherertz T, Shah MM, Balagun O, Wendling N, Van Dyk J, Coleman CN, Xu MJ, Grover S. Mobilising Expertise and Resources to Close the Radiotherapy Gap in Cancer Care. Clin Oncol (R Coll Radiol). 2017 Feb;29(2):135-140. doi: 10.1016/j.clon.2016.11.008. Epub 2016 Dec 9. PMID: 27955997.

13. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries

Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B. The international cancer expert corps: a unique approach for sustainable cancer care in low and […]

12. Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress

Guadagnolo BA, Petereit DG, Coleman CN. Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress. Semin Radiat Oncol. 2017 Apr;27(2):143-149. doi: 10.1016/j.semradonc.2016.11.006. Epub 2016 Nov 24. PMID: 28325240; PMCID: PMC5363281.

10. Training global oncologists: addressing the global cancer control problem

Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training global oncologists: addressing the global cancer control problem. Front Oncol. 2015 Apr 8;5:80. doi: 10.3389/fonc.2015.00080. Erratum in: Front Oncol. 2015;5:133. PMID: 25905040; PMCID: PMC4389376.